|
|
|
Reference
ranges are subject to regular reviews. |
This table is only an approximate guide, as the majority of reference ranges are age related, and quoted on the report form. Therefore, it is important that a patient's date of birth is recorded clearly on the request form. |
|
Test |
Units |
Reference Range |
| Albumin | g/L | 34 - 48 |
| ALT | iu/L | M:<41 F:<31 |
| Alkaline phosphatase | iu/L | M:40-129 F:35-104 |
| Ammonia | umol/L | M:15-55 F:11.2-48.2 |
| Amylase | iu/L | 28 - 100 |
| AST | iu/L | M:<37 F:<31 |
| Bicarbonate | mmol/L | 22.0 - 29.0 |
|
Bilirubin total |
umol/L | <17 |
| Bilirubin direct | umol/L | <5.1 |
| Calcium | mmol/L | 2.15 2.55 |
| Carbamazepine | mg/L | Therapeutic : 4.0 12.0 |
| Creatine Kinase (CK) | iu/L | M:38-174 F:26-140 |
| Creatinine | umol/L | M:62-106 F:44-80 |
| Cholesterol | mmol/L | <5.2 |
| CRP |
mg/L |
<5 |
| CSF Glucose | mmol/L | 2.2 3.9 |
| CSF Protein | g/L | 0.15 0.45 |
| Digoxin | ng/ML | Therapeutic : 0.9 2.0 |
| Gamma GT | iu/L | M:10-71 F:6-42 |
| Glucose | mmol/L | Fasting : 3.9 5.8 |
| Iron | umol/L | M:10.6-28.3 F:6.6-26.0 |
| Lactate | mmol/L | 0.5 2.2 |
| LDH | IU/L | 240 480 |
| Lithium | mmol/L | Therapeutic : 0.6 1.2 |
| Magnesium | mmol/L | 0.65 1.05 |
| Phenytoin | mg/L | Therapeutic : 10 20 |
| Phosphate | mmol/L | 0.87 1.45 |
| Potassium (Serum) | mmol/L | 3.3 5.1 |
| Potassium (Plasma) | mmol/L | 3.3 - 4.5 |
| Sodium | mmol/L | 133 145 |
| Theophylline | mg/L | Therapeutic : 10 20 |
| TIBC | umol/L | 40.8 76.6 |
| Total protein | g/L | 66 87 |
| Triglyceride | mmol/L | <2.3 |
| UIBC | umol/L | 19.7 66.2 |
| Urine Urea | mmol/L | 24 Hr: 250 - 417 |
| Uric acid | umol/L | M:202-417 F:143-339 |
| Urine protein | g/L | Random : <0.12 24 Hr: <1.5 |
| Urea | mmol/L | 1.7 8.3 |
| Analyte | Ref range (adult) | Units | Comments |
| AFP | 0.0 - 10 | kU/L | |
| Androstenedione | 2.1 - 10.8 | nmol/L | Male |
| 1.0 - 11.5 | nmol/L | Female | |
| BNP | 0.0 -100 | pg/mL | Male |
| 0.0 - 150 | pg/mL | Female | |
| CA125 | 0.0 - 21 | kU/L | |
| CA199 | 3.0 - 19.0 | kU/L | |
| CEA | <5.0 | ug/L | |
| Cortisol | 138 - 690 | nmol/L | 09:00 am |
| 79 - 345 | nmol/L | Midnight | |
| HCG | 0.0 - 2.5 | IU/L | Male |
| 0.0 - 5.0 | IU/L | Female | |
| Ferritin | 20 - 322 | ug/mL | Male |
| 10 - 290 | ug/mL | Female | |
| FSH | 2.8 - 14.4 | IU/L | Follicular |
| 5.8 - 21 | IU/L | Mid cycle | |
| 1.2 - 9 | IU/L | Luteal | |
| 21.7 - 153 | IU/L | Post-menopausal | |
| 0.7 - 11.1 | IU/L | Male | |
| Folate | 2.8 - 17 | ng/mL | |
| LH | 1.1 - 11.6 | IU/L | Follicular |
| 17 - 77 | IU/L | Mid Cycle | |
| <14.7 | IU/L | Luteal | |
| 11.3 - 39.8 | IU/L | Postmenopausal | |
| 0.8 - 7.6 | IU/L | Male | |
| Oestradiol | <587 | pmol/L | Follicular |
| 124 - 1469 | pmol/L | Mid cycle | |
| 101 - 905 | pmol/L | Luteal | |
| <110 | pmol/L | Post-menopausal | |
| 0 - 206 | pmol/L | Male | |
| Progesterone | 0.9 - 2.9 | nmol/L | Male |
| Prolactin | 40 - 530 | mIU/L | Female |
| 53 - 360 | mIU/L | Male | |
| PSA | 0.0 - 2.7 | ng/mL | 0 - 49 years |
| 0.0 - 3.4 | ng/mL | 50 - 59 years | |
| 0.0 - 4.4 | ng/mL | 60 - 69 years | |
| 0.0 - 5.5 | ng/mL | 69 - 79 years | |
| 0.0 - 6.5 | ng/mL | 79 years + | |
| PTH | 15 - 65 | pg/mL | |
| SHBG | 15 - 48 | nmol/L | Male |
| 26 - 110 | nmol/L | Female | |
| TA | <35 | IU/L | Normal |
| 35 - 70 | IU/L | Borderline | |
| >70 | IU/L | Positive | |
| Testosterone | 9.9 - 27.8 | nmol/L | Male |
| 0.2 - 2.9 | nmol/L | Female |
Immunology Tests Reference Intervals
| Adult Reference Ranges |
| Test | Reference Range | |||||||||
| Immunoglobulin G (IgG) | 7.0 16.0 g/L | |||||||||
| Immunoglobulin A (IgA) | 0.7 - 4.0 g/L | |||||||||
| Immunoglobulin M (IgM) | 0.4 - 2.3 g/L | |||||||||
| Complement C3 | 0.9 - 1.8 g/L | |||||||||
| Complement C4 | 0.1-0.4 g/L | |||||||||
| Total Immunoglobulin E (IgE) | < 161 kU/L | |||||||||
| Caeruloplasmin | 0.2 - 0.4 g/L | |||||||||
| Tissue transglutaminase antibodies (TTG) |
|
|||||||||
| Rheumatoid Factor (RF) | < 14 IU/mL | |||||||||
| Cardiolipin Antibodies | Normal 0 10 U/mL | |||||||||
| Thyroid Antibodies (Thyroid Peroxisomal TPO) |
|
| Paediatric levels may vary considerably from the above adult ranges. Paediatric ranges are contained in Handbook of Clinical Immunochemistry (Eighth Edition) or advice may be obtained from the laboratory.
To Discuss reference ranges for patients below the age of 18 please contact Clinical Immunology at Heartlands Hospital (ext 40185) |
Haematology Reference Ranges
|
Test |
Age |
Range |
Units |
|
Haemoglobin |
Up to 14 days |
12.0 25.0 |
g/dl |
|
14 days to 1 year |
11.0 13.5 |
g/dl |
|
|
1 to 10 years |
11.0 14.5 |
g/dl |
|
|
Males over 10 years |
12.0 18.0 |
g/dl |
|
|
Females over 10 years |
11.0 16.0 |
g/dl |
|
|
Red Cell Count |
Up to 14 days |
4.0 6.0 |
1012/L |
|
14 days to 12 weeks |
3.2 4.8 |
1012/L |
|
|
12 to 52 weeks |
3.6 5.2 |
1012/L |
|
|
1 to 6 years |
4.1 5.5 |
1012/L |
|
|
7 to 12 years |
4.0 5.4 |
1012/L |
|
|
Males over 12 years |
4.5 5.5 |
1012/L |
|
|
Females over 12 years |
3.8 4.8 |
1012/L |
|
|
Reticulocytes |
All |
0.2 2.0 |
% |
|
Haematocrit |
Adult Male |
0.40 0.50 |
|
|
Adult Female |
0.36 0.46 |
||
|
Mean Cell Volume (MCV) |
Up to 14 days |
90 120 |
fL |
|
|
14 days to 10 years |
76 96 |
fL |
|
Over 10 years |
80 99 |
fL |
|
|
M.C.H. |
All |
27.0 32.0 |
pg |
|
M.C.H.C. |
All |
31.0 35.9 |
% |
|
R.D.W. |
All |
10.0 14.5 |
|
|
Platelets |
All |
150 450 |
109/L |
|
White Cell Count |
Up to 14 days |
6.0 26.0 |
109/L |
|
Over 10 years |
3.5 11.0 |
109/L |
|
|
In Pregnancy |
3.5 15.0 |
109/L |
|
|
Neutrophils |
Up to 14 days |
1.5 13.0 |
109/L |
|
14 days to 1 year |
1.9 7.0 |
109/L |
|
|
1 to 10 years |
1.9 8.0 |
109/L |
|
|
Over 10 years |
1.9 9.0 |
109/L |
|
|
Lymphocytes |
Up to 14 days |
2.0 11.0 |
109/L |
|
14 days to 1 year |
3.0 10.5 |
109/L |
|
|
1 to 10 years |
1.4 6.5 |
109/L |
|
|
Over 10 years |
0.9 4.5 |
109/L |
|
|
Monocytes |
Up to 14 days |
0.1 3.1 |
109/L |
|
Over 10 years |
0.1 2.0 |
109/L |
|
|
Eosinophils |
All |
0 0.5 |
109/L |
|
Basophils |
All |
0 0.2 |
109/L |
| Paediatric ESR |
Male & Female 0 1 4 years |
0 - 20 |
mm/hour |
| Vacutainer ESR |
Male & Female 0 - 7 years |
0 - 20 |
mm/hour |
|
|
Male 7 - 14 years |
0 - 15 |
mm/hour |
|
Female 7 - 14 years |
0 - 20 |
mm/hour |
|
|
|
Male 14 50 years |
0 - 7 |
mm/hour |
|
Female 14 50 years |
0 9 |
mm/hour |
|
|
Male 51 to 60 years |
0 9 |
mm/hour |
|
|
Female 51 to 60 years |
0 14 |
mm/hour |
|
|
Males over 60 years |
0 10 |
mm/hour |
|
|
Females over 60 years |
0 15 |
mm/hour |
|
|
Plasma Viscosity |
All |
1.5 1.72 |
mPas |
|
INR / APPT ratio |
All |
0.8 1.2 |
|
|
Fibrinogen |
All |
1.7 4.0 |
g/L |
Antibiotic Assays : Gentamicin and Vancomycin |
| Performed Monday to Saturday at Good Hope Hospital, but prior notification required by the laboratory. Samples should reach the laboratory by 4.30 pm on Monday to Friday and 12 noon on Saturday. |
| Samples should be taken by a doctor looking after the patient and not a Phlebotomist. |
| The samples required are
as follows:-
|
| VANCOMYCIN normal renal function. See B.N.F. for dose | ||
| Sample Required | Timing | Reference Range |
| Pre dose only | 5 ml clotted blood taken 5 - 30 mins before dose |
5 - 20 mg/L |
Please state dose, time of dose and time blood was taken on request form.
| GENTAMICIN once daily dosing. Discuss dose with Consultant Microbiologist | ||
| Sample Required | Timing | Reference Range |
| 6 - 13 hour post dose only | 5 ml clotted blood taken 6 - 13 hours after dose. Please state exact time |
See nomogram and/or discuss with Microbiologist |
Please state dose, time of dose and time blood was taken on request form.
| GENTAMICIN standard dosing. See B.N.F. for dose | ||
| Sample Required | Timing | Reference Range |
| Pre and post dose levels. | Pre dose 5 mins before dose. Post dose 1 hour after dose. | Pre dose < 2mg/L |
| Post dose 3-5 mg/L for Streptococcus Endocarditis | ||
|
|
Post dose 5-10 mg/L for other infection | |
Please state dose, time of dose and time
blood was taken on request form.
![]()
![]() |